Voters for Cures works to drive patient-centered progress in innovation, affordability and access and pushes for necessary, positive and long-term change to better address the needs of diverse patient communities. As policymakers continue to debate harmful price-setting policies in the form of Most Favored Nation Pricing (MFN), hear what these advocates have to say. 

“We were told price setting would make medicines more affordable. Instead, I’ve seen premiums go up, plan choices disappear and more people denied coverage when starting the medicine they need. Policymakers should focus on solutions that help patients, not double down on failed policies with MFN price controls.”  - Betty L., Kentucky 

"Most of my prescriptions already cost me very little out of pocket. What frustrates me is the exhausting process of dealing with my insurance company who decides if my medicines will be covered and what hoops I have to jump through. Policies like MFN don't change any of that. Policymakers need to focus on real affordability solutions that will actually help patients like me.” - Carl E., Colorado 

“Government price controls won’t lower what I pay at the pharmacy. Insurers and middlemen still decide my coverage, my copay and whether I can get the medicine my doctor prescribed. That’s why policies like MFN price controls worry me. They sound good on paper, but in reality, they won't fix the affordability challenges patients actually face.” - Sue K., Minnesota 

“Patients like me need America to continue to lead the world in developing new medicines. Protecting that leadership helps ensure we have access to the newest treatments first. Policies like MFN concern me greatly because it would allow foreign governments to decide the price of medicines here at home. Real reform should focus on lowering costs by reigning in insurance companies and middlemen, not importing foreign systems we know don’t work. - Mark D., California